GTC Biotherapeutics (fka GTCB)

[keitern]

I think you are right, and also, it is important to note that they are fortunately working on more than one partnership:

"We are in active discussions with potential partners for ATryn as well as for other products in our plasma protein and follow-on biologics portfolios."

and also to keep in mind:

"To illustrate the growing impact of our partnering efforts, today we have already booked and included in our forecast $15 million in respective cash receipts from our currently contracted partners indicating another year of significant revenue growth ahead of us. We will continue to build on this strong base as we add new and expanded collaborations."

I think there will be some sorry sellers after the dust settles here. I bought more at .51 yesterday and will look for opportunities below as I am able.